ClinicalTrials.gg
CompletedNCT00908193ARTEUpdated Aug 2, 2013

Laparoscopic "DA VINCI" Robot Assisted Abdominal Wall Hernia Repair

A Phase 4 interventional study of Laparoscopic DA VINCI Robot Assisted coelioscopy and conventional coelioscopy in Abdominal Wall Hernia, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-08-02.

Sponsored by Assistance Publique - Hôpitaux de Paris · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to prove the superiority of the robotic assistance in laparoscopic repair of abdominal wall hernias .

In this monocentric randomized controlled trial, the use of the DA VINCI robot might reduce the post-operative pain of the patient resulting in a 40% reduction of morphine consumption.

Read the detailed description

Laparoscopic Robot Assisted abdominal wall hernia repair : a prospective randomized trial:

The main judgement criterion is post operative pain reflected by morphine consumption during the first 48 hours. Secondary criteria are morbidity, quality of life, duration of surgery, conversion rate, complications, the the length of stay and hospital costs.

In this single centre study, inclusion criteria are age above 18, no previous repair of the hernia with a mesh and a diameter of the parietal defect of less than 10 cm. Contraindications are chronic use of pain drugs of level II or above and renal insufficiency (clearance \<30ml/min).

The robotic repair was described in a previous paper of our group and will be compared to our classical laparoscopic repair technique, and in both cases with the use of the same prosthetic mesh.

A total of 70 patients to be included in an 18 months period was calculated to prove a 40% reduction in morphine consumption during the postoperative 48h (α=5% and β=10%).

The total duration of the study is 30 months (12 months of follow-up for each patient).

02

Conditions studied

  • Abdominal Wall Hernia

Keywords

  • Treatment of abdominal ruptured
  • Digestive system disease
  • Coelioscopy
  • Assistance robotics
  • Medical device
  • DA VINCI Robot
  • Pain patient
  • Morphine consumption
  • Comparative Randomized study
  • patient over 18 years
  • with ruptured abdominal
  • with an indication of treatment of ruptured
03

In context

Hernia, Abdominal

90 studies on the registry are indexed under Hernia, Abdominal; 18 are open to participants now.

This study's enrollment of 70 is below the median of 96 across 57 interventional studies indexed under Hernia, Abdominal.

Browse Hernia, Abdominal studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,578 studies on the registry; 1,030 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • over 18 years
  • with indication of hernia repair
  • a collar with a diameter of less than 10cm
  • no antecedent of hernia treatment with poses plate
  • agreeing coelioscopy
  • agreeing to participate the clinical study, having sign an informed consent
  • agreeing a regular monitor

Exclusion criteria

Exclusion Criteria:

  • taking analgesic tier 2 or 3
  • against indication to anesthetics or coelioscopy
  • creatinine clearance less than 30 ml/min
  • pregnant woman and protected persons
  • no affiliation to social security
  • unable to understand the information form
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    1

    robot-assisted coelioscopy

    Device: Laparoscopic DA VINCI Robot Assisted coelioscopy

  • Active comparator
    2

    conventional coelioscopy

    Procedure: conventional coelioscopy

Interventions

  • DeviceLaparoscopic DA VINCI Robot Assisted coelioscopy

    Patients with abdominal wall hernia will be treated by robot-assisted coelioscopy for the poses of abdominal plate

    Also known as: Laparoscopic DA VINCI Robot Assisted abdominal coelioscopy

  • Procedureconventional coelioscopy

    Patients with abdominal wall hernia will be treated by conventional coelioscopy for the poses of abdominal plate

06

What researchers measure

Primary outcomes

  1. Evaluate the reduction in morphine consumption

    Time frame: during the postoperative 48h

Secondary outcomes

  1. Pain patient (ENS, total consumption of morphine)

    Time frame: during the hospitalization, to 10 days,1 month, 6 months and 12 months of surgery

  2. quality of life (questionary SF-36)

    Time frame: 1 month, 6 month and 12 month of surgery

  3. length of stay in hospital, percentage return home to 24 hours of surgery

    Time frame: to 24 hours of surgery

  4. morbidity

    Time frame: during the study

  5. resumption of work

    Time frame: after surgery

07

Study locations

1 site
  • Groupe Hospitalier Chenevier-Mondor
    Créteil, 94000, France
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2007, a primary completion of Jun 2012 and a completion of Jun 2012. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2009
First posted
May 25, 2009
Start
Jul 2007
Primary completionActual
Jun 2012
CompletionActual
Jun 2012
Last update
Aug 2, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 2, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00908193
Responsible party
Sponsor
First posted
May 25, 2009
Start date
Jul 2007
Primary completion
Jun 2012
Completion
Jun 2012
Last update
Aug 2, 2013

Study contacts

Claude Tayar
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion